Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.

Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025 ...

Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A couple of days ago, fans of Nandamuri Balakrishna raised a significant outcry, alleging that Andhra Jyothy failed to cover their hero's speech and did not even mention his name in the daily, ...

15-May-24-03-Jul-24 3.5 Rs.3.5000 per share(350%)Final Dividend 03-May-23-03-Jul-23 3 Rs.3.0000 per share(300%)Final Dividend 24-May-22-01-Jul-22 2.5 Rs.2.5000 per share(250%)Final Dividend 18-May ...